For citations:
Demidova T.Yu., Titova V.V., Skuridina D.V. Advantages of glucagon-like peptide agonists in the light of prevention of cardiovascular and renal complications. FOCUS. Endocrinology. 2023;4(4):18-25. (In Russ.) https://doi.org/10.15829/2713-0177-2023-4-23